Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 330  Show
  1. 1
    "Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system."
    Petersen T.E., Martzen M.R., Ichinose A., Davie E.W.
    J. Biol. Chem. 265:6104-6111(1990) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT ASN-472.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    "Molecular cloning and characterization of a full-length cDNA clone for human plasminogen."
    Forsgren M., Raden B., Israelsson M., Larsson K., Heden L.-O.
    FEBS Lett. 213:254-260(1987) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  3. 3
    "Expression of recombinant human plasminogen and aglycoplasminogen in HeLa cells."
    Browne M.J., Chapman C.G., Dodd I., Carey J.E., Lawrence G.M.P., Mitchell D., Robinson J.H.
    Submitted (OCT-1991) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Tissue: Liver.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    SeattleSNPs variation discovery resource
    Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS LYS-57; GLN-133; HIS-261; TRP-408; ASN-472; VAL-494 AND TRP-523.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  5. 5
    "The DNA sequence and analysis of human chromosome 6."
    Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D.
    Beck S.
    Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3739 other entries.

  6. 6
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ASP-676.
    Category: Sequences.
    Tissue: Kidney.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50464 other entries.

  7. 7
    Sottrup-Jensen L., Petersen T.E., Magnusson S.
    Submitted (JUL-1977) to the PIR data bank
    Cited for: PROTEIN SEQUENCE OF 20-810, VARIANT ASN-472.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  8. 8
    "Structural relationship between 'glutamic acid' and 'lysine' forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography."
    Wiman B., Wallen P.
    Eur. J. Biochem. 50:489-494(1975) [PubMed] [Europe PMC] [Abstract]
    Cited for: PROTEIN SEQUENCE OF 20-100.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  9. 9
    "The primary structure of human plasminogen."
    Sottrup-Jensen L., Claeys H., Zajdel M., Petersen T.E., Magnusson S.
    (In) Davidson J.F., Rowan R.M., Samama M.M., Desnoyers P.C. (eds.); Progress in chemical fibrinolysis and thrombolysis, pp.3:191-209, Raven Press, New York (1978)
    Cited for: PROTEIN SEQUENCE OF 95-580; 581-626; 657-700 AND 732-810, VARIANT ASN-472.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  10. 10
    "Characterization of a complementary deoxyribonucleic acid coding for human and bovine plasminogen."
    Malinowski D.P., Sadler J.E., Davie E.W.
    Biochemistry 23:4243-4250(1984) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 292-810.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 other entries.

  11. 11
    "Amino-acid sequence of the cyanogen-bromide fragment from human plasminogen that forms the linkage between the plasmin chains."
    Wiman B., Wallen P.
    Eur. J. Biochem. 58:539-547(1975) [PubMed] [Europe PMC] [Abstract]
    Cited for: PROTEIN SEQUENCE OF 483-604.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  12. 12
    "Primary structure of the B-chain of human plasmin."
    Wiman B.
    Eur. J. Biochem. 76:129-137(1977) [PubMed] [Europe PMC] [Abstract]
    Cited for: PROTEIN SEQUENCE OF 581-810.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  13. 13
    "The primary structure of human plasminogen. II. The histidine loop of human plasmin: light (B) chain active center histidine sequence."
    Robbins K.C., Bernabe P., Arzadon L., Summaria L.
    J. Biol. Chem. 248:1631-1633(1973) [PubMed] [Europe PMC] [Abstract]
    Cited for: ACTIVE SITE.
    Category: Function.
    Source: UniProtKB/Swiss-Prot (reviewed).
  14. 14
    "Studies on the active center of human plasmin. Partial amino acid sequence of a peptide containing the active center serine residue."
    Groskopf W.R., Summaria L., Robbins K.C.
    J. Biol. Chem. 244:3590-3597(1969) [PubMed] [Europe PMC] [Abstract]
    Cited for: ACTIVE SITE.
    Category: Function.
    Source: UniProtKB/Swiss-Prot (reviewed).
  15. 15
    "Structure of the omega-aminocarboxylic acid-binding sites of human plasminogen. Arginine 70 and aspartic acid 56 are essential for binding of ligand by kringle 4."
    Trexler M., Vali Z., Patthy L.
    J. Biol. Chem. 257:7401-7406(1982) [PubMed] [Europe PMC] [Abstract]
    Cited for: OMEGA-AMINOCARBOXYLIC ACID-BINDING SITES.
    Category: Function.
    Source: UniProtKB/Swiss-Prot (reviewed).
  16. 16
    "The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain."
    Vali Z., Patthy L.
    J. Biol. Chem. 259:13690-13694(1984) [PubMed] [Europe PMC] [Abstract]
    Cited for: FIBRIN AND OMEGA-AMINOCARBOXYLIC ACID BINDING SITES.
    Category: Function.
    Source: UniProtKB/Swiss-Prot (reviewed).
  17. 17
    "Serine-578 is a major phosphorylation locus in human plasma plasminogen."
    Wang H., Prorok M., Bretthauer R.K., Castellino F.J.
    Biochemistry 36:8100-8106(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION AT SER-597.
    Category: PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).
  18. 18
    "The N- and O-linked carbohydrate chains of human, bovine and porcine plasminogen. Species specificity in relation to sialylation and fucosylation patterns."
    Marti T., Schaller J., Rickli E.E., Schmid K., Kamerling J.P., Gerwig G.J., van Halbeek H., Vliegenthart J.F.G.
    Eur. J. Biochem. 173:57-63(1988) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION AT SER-268; ASN-308 AND THR-365, STRUCTURE OF CARBOHYDRATES.
    Category: PTM / Processing, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 other entries.

  19. 19
    "Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein."
    Borza D.B., Morgan W.T.
    J. Biol. Chem. 272:5718-5726(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH HRG.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  20. 20
    "Evidence for a novel O-linked sialylated trisaccharide on Ser-248 of human plasminogen 2."
    Pirie-Shepherd S.R., Stevens R.D., Andon N.L., Enghild J.J., Pizzo S.V.
    J. Biol. Chem. 272:7408-7411(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION AT SER-268.
    Category: PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).
  21. 21
    "Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma."
    O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., Folkman J.
    Cell 79:315-328(1994) [PubMed] [Europe PMC] [Abstract]
    Cited for: CHARACTERIZATION OF ANGIOSTATIN, PARTIAL PROTEIN SEQUENCE.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  22. 22
    "A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer."
    Sim B.K., O'Reilly M.S., Liang H., Fortier A.H., He W., Madsen J.W., Lapcevich R., Nacy C.A.
    Cancer Res. 57:1329-1334(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: CHARACTERIZATION OF ANGIOSTATIN.
    Source: UniProtKB/Swiss-Prot (reviewed).
  23. 23
    "Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3)."
    Lijnen H.R., Ugwu F., Bini A., Collen D.
    Biochemistry 37:4699-4702(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: PROTEOLYTIC CLEAVAGE.
    Category: PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).
  24. 24
    Cited for: INTERACTION WITH ATP5F1A, SUBCELLULAR LOCATION.
    Category: Subcellular Location, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  25. 25
    "Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen)."
    Goretzki L., Lombardo C.R., Stallcup W.B.
    J. Biol. Chem. 275:28625-28633(2000) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH CSPG4, DOMAIN.
    Category: Interaction, Family & Domains.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

1 to 25 of 330  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again